Shuttle Pharmaceuticals Stock Today

SHPH Stock  USD 0.46  0.02  4.55%   


6 of 100


Odds Of Distress

Over 73

Shuttle Pharmaceuticals is trading at 0.46 as of the 22nd of July 2024. This is a 4.55 percent increase since the beginning of the trading day. The stock's open price was 0.44. Shuttle Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Shuttle Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of June 2024 and ending today, the 22nd of July 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
31st of August 2022
Health Care
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. The company was founded in 2012 and is based in Rockville, Maryland. The company has 16.79 M outstanding shares of which 31.01 K shares are at this time shorted by private and institutional investors with about 0.32 trading days to cover. More on Shuttle Pharmaceuticals

Moving against Shuttle Stock

  0.42LH Laboratory Earnings Call This WeekPairCorr
  0.4CELC Celcuity LLCPairCorr

Shuttle Stock Highlights

President COOMD MBA
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities1.1 MM
Notably Up
Slightly volatile
Non Current Liabilities Total525.4 K853.7 K
Way Down
Slightly volatile
Total Assets4.3 MM
Way Down
Slightly volatile
Total Current Assets5.9 M5.6 M
Sufficiently Up
Slightly volatile
Shuttle Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shuttle Pharmaceuticals' financial leverage. It provides some insight into what part of Shuttle Pharmaceuticals' total assets is financed by creditors.
Shuttle Pharmaceuticals currently holds 1.09 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Shuttle Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Shuttle Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.


Shuttle Pharmaceuticals (SHPH) is traded on NASDAQ Exchange in USA. It is located in One Research Court, Rockville, MD, United States, 20850 and employs 8 people. Shuttle Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.73 M. Shuttle Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 16.79 M outstanding shares of which 31.01 K shares are at this time shorted by private and institutional investors with about 0.32 trading days to cover. Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (5.58 M) of positive cash flow from operations.
Check Shuttle Pharmaceuticals Probability Of Bankruptcy
Ownership Allocation
Shuttle Pharmaceuticals shows a total of 16.79 Million outstanding shares. Shuttle Pharmaceuticals maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shuttle Ownership Details

Shuttle Stock Institutional Holders

InstituionRecorded OnShares
Geode Capital Management, Llc2024-03-31
37 K
Renaissance Technologies Corp2024-03-31
16.5 K
Virtu Financial Llc2024-03-31
10.5 K
Ubs Group Ag2024-03-31
1.1 K
Tower Research Capital Llc2024-03-31
Wells Fargo & Co2024-03-31
Stonex Group Inc2024-03-31
View Shuttle Pharmaceuticals Diagnostics

Shuttle Pharmaceuticals Historical Income Statement

As of now, Shuttle Pharmaceuticals' Total Operating Expenses is increasing as compared to previous years. View More Fundamentals

Shuttle Stock Against Markets

Shuttle Pharmaceuticals Corporate Management

Michael StarkweatherVP DevelProfile
CSC MDChief CoFounderProfile
Gene EsqGeneral CounselProfile
Mira JungCoFounder BiologyProfile
Tyvin MDChief OfficerProfile
Anatoly MDMD, CoFounderProfile

Additional Information and Resources on Investing in Shuttle Stock

When determining whether Shuttle Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Shuttle Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Shuttle Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Shuttle Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.